Immune-related saliva micro-RNA’s to predict clinical response to a combination of cetuximab and low-dose chemotherapy in head and neck cancer (HNSCC) patients (pts) with poor performance status (PS).
LONDON--(BUSINESS WIRE)--Technavio’s latest market research report on the global voice prosthesis devices market provides an analysis of the most important trends expected to impact the market outlook ...
Key voice prosthesis devices companies include Atos Medical (Coloplast A/S), InHealth Technologies, Andreas Fahl Medical Technology Sales GmbH, Hood Laboratories, Smiths Medical, Passy-Muir, Inc., ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback